Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

60

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 60 (100%)

Discontinuation Reports

28

To be discontinued: 0 (0%)
Discontinued: 28 (100%)
Reversed: 0 (0%)

Late reports

39 (44%)

Overdue reports

0 (0%)

Showing 61 to 60 of 60

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-NABILONE 1MG CAPSULE Discontinued 2018-05-31 2018-06-01 50986
RAN-NABILONE 0.25MG CAPSULE Discontinued 2018-05-31 2018-06-01 50989
RAN-NABILONE 0.5MG CAPSULE Discontinued 2018-05-31 2018-06-01 50992
RAN-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91278
RAN-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91281
RAN-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-02-02 2020-02-02 105096
RAN-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-03-07 2020-03-07 108130
RAN-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Discontinued 2017-07-21 2017-07-21 16588

Showing 21 to 28 of 28